Abstract
Major depression is a serious public health problem and one of the most common psychiatric disorders, and it is estimated that millions of people are affected worldwide. In addition, patients having depression present cognitive impairments, which could influence treatment adherence and long-term outcomes. Although, studies have shown that alterations in the hypothalamic–pituitary–adrenal axis, in inflammatory and antioxidant systems, and changes in intracellular pathways are involved in the cognitive impairment verified in depressive patients, it was unclear how these alterations occur. In this context, animal models of psychiatric disorders are revealed as good alternatives for the study of pathophysiology of these and associated factors. Thus, this review will highlight studies with animal models that have helped in understanding the mechanisms involved in cognitive impairment associated with depression, as well as focus on effective treatments that assist in improving both depression and cognition.
Keywords: Animal models, cellular survival pathway, cognition, depression, immune system, neuroendocrine system.
CNS & Neurological Disorders - Drug Targets
Title:Cognitive Dysfunction in Depression: Lessons Learned from Animal Models
Volume: 13 Issue: 10
Author(s): Gislaine Z. Reus, Helena M. Abelaira, Daniela D. Leffa and Joao Quevedo
Affiliation:
Keywords: Animal models, cellular survival pathway, cognition, depression, immune system, neuroendocrine system.
Abstract: Major depression is a serious public health problem and one of the most common psychiatric disorders, and it is estimated that millions of people are affected worldwide. In addition, patients having depression present cognitive impairments, which could influence treatment adherence and long-term outcomes. Although, studies have shown that alterations in the hypothalamic–pituitary–adrenal axis, in inflammatory and antioxidant systems, and changes in intracellular pathways are involved in the cognitive impairment verified in depressive patients, it was unclear how these alterations occur. In this context, animal models of psychiatric disorders are revealed as good alternatives for the study of pathophysiology of these and associated factors. Thus, this review will highlight studies with animal models that have helped in understanding the mechanisms involved in cognitive impairment associated with depression, as well as focus on effective treatments that assist in improving both depression and cognition.
Export Options
About this article
Cite this article as:
Reus Z. Gislaine, Abelaira M. Helena, Leffa D. Daniela and Quevedo Joao, Cognitive Dysfunction in Depression: Lessons Learned from Animal Models, CNS & Neurological Disorders - Drug Targets 2014; 13 (10) . https://dx.doi.org/10.2174/1871527313666141130223453
DOI https://dx.doi.org/10.2174/1871527313666141130223453 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases
Current Drug Targets Role of Gut Microbiota in Human Health and Diseases
Current Nutrition & Food Science Systemic Lupus Erythematosus-Related Interstitial Lung Disease
Current Rheumatology Reviews Lymphocyte Homing to the Liver
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Potential Targets for Intervention in Radiation-Induced Heart Disease
Current Drug Targets Possible Underestimation by Sports Medicine of the Effects of Early Physical Exercise Practice on the Prevention of Diseases in Adulthood
Current Diabetes Reviews Implication of Medical Treatment for Surgical Strategies in IBD
Current Drug Targets Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Current Medicinal Chemistry Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Medicinal Chemistry New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus
Current Medicinal Chemistry Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
Current Genomics Pharmacological and Clinical Studies on Purine Nucleoside Analogs- New Anticancer Agents
Mini-Reviews in Medicinal Chemistry Somatic Genome Variations in Health and Disease
Current Genomics Gender as a Regulator of Atherosclerosis in Murine Models
Current Drug Targets Approaching Clinical Reality: Markers for Monitoring Systemic Inflammation and Sepsis
Current Molecular Medicine Meet the Editorial Board
Combinatorial Chemistry & High Throughput Screening Rational Synthesis of Ibandronate and Alendronate
Current Organic Synthesis Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Current Medicinal Chemistry